Nanovibronix, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
ENvue Medical, Inc. (formerly NanoVibronix, Inc.) filed its annual report detailing significant operational changes, including a merger and reverse stock splits, while addressing Nasdaq listing requirements and ongoing financial challenges.
NanoVibronix finalizes its merger with ENvue Medical, secures $1.3 million in debenture financing, and implements a 1-for-11 reverse stock split to meet Nasdaq requirements.
NanoVibronix files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
NanoVibronix has filed an amendment to its annual report to correct the location of its former auditor's consent and include updated certifications.
NanoVibronix, Inc. details its capital structure, product development, and regulatory strategies in its annual 10-K filing.